Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery (The POPular CABG Study)
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Oct 2023
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes; Coronary artery disease; Vascular graft occlusion
- Focus Therapeutic Use
- Acronyms POPular CABG
- 31 Aug 2020 Primary endpoint (Saphenous vein graft occlusion) has not been met according to the results published in the Circulation
- 31 Aug 2020 Results published in the Circulation
- 16 Mar 2020 Planned End Date changed from 1 Feb 2020 to 1 Aug 2020.